File Download
 
 
Supplementary

Conference Paper: Effects of Chelators (Desferal, Deferiprone & Deferaairox) on the Growth of Klebsiella and Aeromonas Isolated from Transfusion Dependent Thalassemia Patients
  • Basic View
  • Metadata View
  • XML View
TitleEffects of Chelators (Desferal, Deferiprone & Deferaairox) on the Growth of Klebsiella and Aeromonas Isolated from Transfusion Dependent Thalassemia Patients
 
AuthorsChan, GCF
Chan, S
Ho, PL
Ha, SY
 
Issue Date2010
 
PublisherMedcom Limited. The Journal's web site is located at http://www.hkjpaed.org/index.asp
 
CitationJoint Annual Scientific Meeting of the Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association, Hong Kong, China, 28 November, 2009. In the Hong Kong Journal of Paediatrics (New series), 2010, v. 15 n. 1, p. 81 [How to Cite?]
 
AbstractInfection is among the leading causes of death for thalassemia major patients. The known predisposing factors of infection include prior splenectomy, iron overload and use of iron chelator such as desferal (desferrioxamine). While encapsulated organisms frequently found in splenectomized patients were readily controlled by prophylactic vaccination and vigilant antibiotic treatment, ferrophilic organisms such as Yersinia and Klebsiella remains common among Thalassemic patients. The inductive iron overloaded environment favours the growth of these organisms but their growth is also affected by the environment temperature. For example, Yersinia infection is more prevalent in temperate regions and Klebsiella infection is commonly found in subtropical areas. Furthermore, the use of iron chelator in the form of desferal further aggravates the risk of Yersinia infection. It is because the iron membrane transport protein siderophore found in desferal can be adopted by the bacteria for iron acquisition. However, oral chelators such as deferiprone do not enhance growth of Yersinia in vitro or in vivo. In order to find out whether such observation can be extended to Klebsiella and Aeromona infection, in vitro culture assay using Klebsiella pneumoniae and Aeromonas hydrophila obtained directly from our transfusion dependent thalassaemic patients were performed. The growth rates of the bacteria under iron rich, iron poor with or without different chelators were assessed. The growth rates were analyzed by both: (1) optic density of bacterial broth; and (2) colony count by bacterial agar plate. We found that the growth of Klebsiella was marginally enhanced by desferal in vitro when compared to Yersinia. Such unfavourable effect was not found in either deferiprone or deferasirox in vitro. On the other hand, the growth of Aeromonas was not affected by the presence of any of the 3 chelators. Therefore, we suggested that factors other than desferal may account for the increase prevalence of Klebsiella and Aeromonas infection among Asian thalassemic patients. It also suggests that oral chelators are safe for thalassemic patients during febrile illness. Unlike desferal, withholding iron chelator during infectious period may not be mandatory. But care has to be exercised especially for patients on deferiprone, since neutropenia has to be ruled out during febrile illness. This project was supported by the Children's Thalassaemia Foundations
 
DescriptionPoster Presentation (Doctor’s Session)
 
ISSN1013-9923
2013 Impact Factor: 0.106
2013 SCImago Journal Rankings: 0.126
 
DC FieldValue
dc.contributor.authorChan, GCF
 
dc.contributor.authorChan, S
 
dc.contributor.authorHo, PL
 
dc.contributor.authorHa, SY
 
dc.date.accessioned2010-09-25T20:57:02Z
 
dc.date.available2010-09-25T20:57:02Z
 
dc.date.issued2010
 
dc.description.abstractInfection is among the leading causes of death for thalassemia major patients. The known predisposing factors of infection include prior splenectomy, iron overload and use of iron chelator such as desferal (desferrioxamine). While encapsulated organisms frequently found in splenectomized patients were readily controlled by prophylactic vaccination and vigilant antibiotic treatment, ferrophilic organisms such as Yersinia and Klebsiella remains common among Thalassemic patients. The inductive iron overloaded environment favours the growth of these organisms but their growth is also affected by the environment temperature. For example, Yersinia infection is more prevalent in temperate regions and Klebsiella infection is commonly found in subtropical areas. Furthermore, the use of iron chelator in the form of desferal further aggravates the risk of Yersinia infection. It is because the iron membrane transport protein siderophore found in desferal can be adopted by the bacteria for iron acquisition. However, oral chelators such as deferiprone do not enhance growth of Yersinia in vitro or in vivo. In order to find out whether such observation can be extended to Klebsiella and Aeromona infection, in vitro culture assay using Klebsiella pneumoniae and Aeromonas hydrophila obtained directly from our transfusion dependent thalassaemic patients were performed. The growth rates of the bacteria under iron rich, iron poor with or without different chelators were assessed. The growth rates were analyzed by both: (1) optic density of bacterial broth; and (2) colony count by bacterial agar plate. We found that the growth of Klebsiella was marginally enhanced by desferal in vitro when compared to Yersinia. Such unfavourable effect was not found in either deferiprone or deferasirox in vitro. On the other hand, the growth of Aeromonas was not affected by the presence of any of the 3 chelators. Therefore, we suggested that factors other than desferal may account for the increase prevalence of Klebsiella and Aeromonas infection among Asian thalassemic patients. It also suggests that oral chelators are safe for thalassemic patients during febrile illness. Unlike desferal, withholding iron chelator during infectious period may not be mandatory. But care has to be exercised especially for patients on deferiprone, since neutropenia has to be ruled out during febrile illness. This project was supported by the Children's Thalassaemia Foundations
 
dc.description.naturepublished_or_final_version
 
dc.descriptionPoster Presentation (Doctor’s Session)
 
dc.identifier.citationJoint Annual Scientific Meeting of the Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association, Hong Kong, China, 28 November, 2009. In the Hong Kong Journal of Paediatrics (New series), 2010, v. 15 n. 1, p. 81 [How to Cite?]
 
dc.identifier.epage81
 
dc.identifier.hkuros168352
 
dc.identifier.issn1013-9923
2013 Impact Factor: 0.106
2013 SCImago Journal Rankings: 0.126
 
dc.identifier.issue1
 
dc.identifier.spage81
 
dc.identifier.urihttp://hdl.handle.net/10722/103078
 
dc.identifier.volume15
 
dc.languageeng
 
dc.publisherMedcom Limited. The Journal's web site is located at http://www.hkjpaed.org/index.asp
 
dc.publisher.placeHong Kong
 
dc.relation.ispartofHong Kong Journal of Paediatrics (New series)
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.titleEffects of Chelators (Desferal, Deferiprone & Deferaairox) on the Growth of Klebsiella and Aeromonas Isolated from Transfusion Dependent Thalassemia Patients
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Chan, GCF</contributor.author>
<contributor.author>Chan, S</contributor.author>
<contributor.author>Ho, PL</contributor.author>
<contributor.author>Ha, SY</contributor.author>
<date.accessioned>2010-09-25T20:57:02Z</date.accessioned>
<date.available>2010-09-25T20:57:02Z</date.available>
<date.issued>2010</date.issued>
<identifier.citation>Joint Annual Scientific Meeting of the Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association, Hong Kong, China, 28 November, 2009. In the Hong Kong Journal of Paediatrics (New series), 2010, v. 15  n. 1, p. 81</identifier.citation>
<identifier.issn>1013-9923</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/103078</identifier.uri>
<description>Poster Presentation (Doctor&#8217;s Session)</description>
<description.abstract>Infection is among the leading causes of death for
thalassemia major patients. The known predisposing factors
of infection include prior splenectomy, iron overload and
use of iron chelator such as desferal (desferrioxamine).
While encapsulated organisms frequently found in
splenectomized patients were readily controlled by
prophylactic vaccination and vigilant antibiotic treatment,
ferrophilic organisms such as Yersinia and Klebsiella
remains common among Thalassemic patients. The
inductive iron overloaded environment favours the growth
of these organisms but their growth is also affected by the
environment temperature. For example, Yersinia infection
is more prevalent in temperate regions and Klebsiella
infection is commonly found in subtropical areas.
Furthermore, the use of iron chelator in the form of desferal
further aggravates the risk of Yersinia infection. It is because
the iron membrane transport protein siderophore found in
desferal can be adopted by the bacteria for iron acquisition. However, oral chelators such as deferiprone do not enhance
growth of Yersinia in vitro or in vivo. In order to find out
whether such observation can be extended to Klebsiella and
Aeromona infection, in vitro culture assay using Klebsiella
pneumoniae and Aeromonas hydrophila obtained directly
from our transfusion dependent thalassaemic patients were
performed. The growth rates of the bacteria under iron rich,
iron poor with or without different chelators were assessed.
The growth rates were analyzed by both: (1) optic density
of bacterial broth; and (2) colony count by bacterial agar
plate. We found that the growth of Klebsiella was marginally
enhanced by desferal in vitro when compared to Yersinia.
Such unfavourable effect was not found in either deferiprone
or deferasirox in vitro. On the other hand, the growth of
Aeromonas was not affected by the presence of any of the 3
chelators. Therefore, we suggested that factors other than
desferal may account for the increase prevalence of
Klebsiella and Aeromonas infection among Asian
thalassemic patients. It also suggests that oral chelators are
safe for thalassemic patients during febrile illness. Unlike
desferal, withholding iron chelator during infectious period
may not be mandatory. But care has to be exercised
especially for patients on deferiprone, since neutropenia has
to be ruled out during febrile illness.
This project was supported by the Children&apos;s Thalassaemia
Foundations</description.abstract>
<language>eng</language>
<publisher>Medcom Limited. The Journal&apos;s web site is located at http://www.hkjpaed.org/index.asp</publisher>
<relation.ispartof>Hong Kong Journal of Paediatrics (New series)</relation.ispartof>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<title>Effects of Chelators (Desferal, Deferiprone &amp; Deferaairox) on the Growth of Klebsiella and Aeromonas Isolated from Transfusion Dependent Thalassemia Patients</title>
<type>Conference_Paper</type>
<description.nature>published_or_final_version</description.nature>
<identifier.hkuros>168352</identifier.hkuros>
<identifier.volume>15</identifier.volume>
<identifier.issue>1</identifier.issue>
<identifier.spage>81</identifier.spage>
<identifier.epage>81</identifier.epage>
<publisher.place>Hong Kong</publisher.place>
<bitstream.url>http://hub.hku.hk/bitstream/10722/103078/1/Abstract.pdf</bitstream.url>
</item>